ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $101,000 | +17.4% | 68,958 | +13.8% | 0.00% | – |
| Q4 2016 | $86,000 | -13.1% | 60,600 | +7.0% | 0.00% | – |
| Q3 2016 | $99,000 | +2.1% | 56,656 | +0.4% | 0.00% | – |
| Q2 2016 | $97,000 | +54.0% | 56,438 | +75.9% | 0.00% | – |
| Q1 2016 | $63,000 | -3.1% | 32,087 | -6.2% | 0.00% | – |
| Q4 2015 | $65,000 | +3.2% | 34,217 | +3.4% | 0.00% | – |
| Q3 2015 | $63,000 | -59.6% | 33,080 | -1.3% | 0.00% | – |
| Q2 2015 | $156,000 | -98.5% | 33,515 | -98.9% | 0.00% | -100.0% |
| Q4 2014 | $10,294,000 | -8.0% | 2,966,665 | +11.1% | 0.00% | 0.0% |
| Q3 2014 | $11,187,000 | +27.6% | 2,669,924 | +78.4% | 0.00% | +33.3% |
| Q2 2014 | $8,770,000 | -24.6% | 1,496,630 | -19.0% | 0.00% | -40.0% |
| Q1 2014 | $11,638,000 | +63.0% | 1,847,224 | +51.4% | 0.01% | +66.7% |
| Q4 2013 | $7,139,000 | +53.9% | 1,220,356 | +38.7% | 0.00% | +50.0% |
| Q3 2013 | $4,638,000 | – | 879,988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |